An anti-cancer surveillance by the interplay between interferon-beta and retinoblastoma protein RB1
Interferon-beta (IFN-β), an extracellular cytokine that initiates signaling pathways for gene regulation, has been demonstrated to function as a tumor suppressor protein through lentiviral gene transduction. In this article, I review the relevant previous works and propose a cell cycle-based, tumor...
Main Author: | Albert Qin |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2023-04-01
|
Series: | Frontiers in Oncology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fonc.2023.1173467/full |
Similar Items
-
High-Level MYCN-Amplified RB1-Proficient Retinoblastoma Tumors Retain Distinct Molecular Signatures
by: Khashayar Roohollahi, MSc, et al.
Published: (2022-09-01) -
Subsequent Malignant Neoplasms in Retinoblastoma Survivors
by: Armida W. M. Fabius, et al.
Published: (2021-03-01) -
Significance of the interferon (IFN) in the therapy
by: Sabina Mahmutović, et al.
Published: (2004-11-01) -
Clinical and genetic characteristics of retinoblastoma patients in a single center with four novel RB1 variants
by: Özge Vural, et al.
Published: (2023-08-01) -
Forms and Methods for Interferon’s Encapsulation
by: Thelvia I. Ramos, et al.
Published: (2021-09-01)